日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents

结合突变和细胞遗传学特征的急性髓系白血病预后模型(采用维奈托克和去甲基化药物治疗)

Drekolias, Dimitrios; Tuz Zahra, Fatima; Fileni, Caroline; Sallman, David A; Mo, Qianxing; Chan, Onyee; Zhang, Ling; Vincelette, Nicole D; Yu, Xiaoqing; Sammut, Rinzine; Moon, Jungwon; Park, Junyoung; Umasangtongkul, Sura-Attha; Lledo, Felyschia M; Razabdouski, Tiffany N; Cheng, Chia-Ho; Qin, Dahui; Mai, Kathy; Ball, Somedeb; Shallis, Rory M; Xie, Zhuoer; Kuykendall, Andrew T; Padron, Eric; Sweet, Kendra; Walker, Alison R; Komrokji, Rami S; Lancet, Jeffrey E; Niyongere, Sandrine; Cluzeau, Thomas; Yun, Seongseok

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病的氨基酸调节剂pegcrisantaspase和venetoclax的I期研究

Liu, Yuchen; Bollino, Dominique R; Bah, Osman M; Strovel, Erin T; Le, Tien V; Zarrabi, Jinoos; Philip, Sunita; Lapidus, Rena G; Baer, Maria R; Niyongere, Sandrine; Duong, Vu H; Dougherty, Christine C; Beumer, Jan H; Caprinolo, Katherine D; Kamangar, Farin; Emadi, Ashkan

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.

DNA甲基转移酶抑制剂地西他滨和PARP抑制剂他拉唑帕尼联合治疗复发/难治性急性髓系白血病的I期临床试验

Baer Maria R, Kogan Aksinija A, Bentzen Søren M, Mi Tian, Lapidus Rena G, Duong Vu H, Emadi Ashkan, Niyongere Sandrine, O'Connell Casey L, Youngblood Benjamin A, Baylin Stephen B, Rassool Feyruz V

Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

FLT3-ITD插入长度对急性髓系白血病预后的影响:一项倾向评分调整队列研究

Corley, Elizabeth M; Mustafa Ali, Moaath K; Alharthy, Hanan; Kline, Kathryn A F; Sewell, Danielle; Law, Jennie Y; Lee, Seung Tae; Niyongere, Sandrine; Duong, Vu H; Baer, Maria R; Emadi, Ashkan

Therapy-related B-lymphoblastic leukemia after multiple myeloma

多发性骨髓瘤后治疗相关性B淋巴母细胞白血病

Kallen, Michael E; Koka, Rima; Singh, Zeba N; Ning, Yi; Kocoglu, Mehmet H; Badros, Ashraf Z; Niyongere, Sandrine; Duong, Vu H; Emadi, Ashkan; Baer, Maria R

Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia

一项整合了人类和小鼠的临床研究证实了鲁索替尼治疗慢性粒单核细胞白血病的临床疗效。

Hunter, Anthony M; Newman, Hannah; Dezern, Amy E; Steensma, David P; Niyongere, Sandrine; Roboz, Gail J; Mo, Qianxing; Chan, Onyee; Gerds, Aaron; Sallman, David A; Dominguez-Viqueira, William; Letson, Christopher; Balasis, Maria E; Ball, Markus; Kruer, Traci; Zhang, Hailing; Lancet, Jeffrey E; List, Alan F; Sekeres, Mikkael A; Komrokji, Rami S; Padron, Eric

Check(point) or checkmate for acute myeloid leukemia?

急性髓系白血病的转折点还是绝境?

Niyongere, Sandrine; Rapoport, Aaron P

Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer

非小细胞肺癌的免疫疗法联合策略(非化疗)

Niyongere, Sandrine; Saltos, Andreas; Gray, Jhanelle E

Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population

阿拉巴马州普通人群中白人和非裔美国人血色素沉着蛋白基因 (HJV) I222N 和 G320V 错义突变的等位基因频率

Barton, James C; Rivers, Charles A; Niyongere, Sandrine; Bohannon, Sean B; Acton, Ronald T